Breaking News Instant updates and real-time market news.

PRQR

ProQR Therapeutics

$18.00

-0.16 (-0.88%)

07:12
12/10/18
12/10
07:12
12/10/18
07:12

ProQR Therapeutics receives EUR4.7M credit from Dutch government for QR-110

ProQR Therapeutics announced that it was awarded an innovation credit by the Dutch government for the clinical development and efforts to obtain marketing approval for the QR-110 program that is being developed for patients with Leber's congenital amaurosis 10, or LCA10, a genetic eye disease that is the leading cause of childhood blindness. Repayment of the credit is triggered only by market approval of QR-110. ProQR was awarded an Innovation credit for the QR-110 program. Amounts will be drawn under this facility from 2018-2021.The credit of EUR4.7M through December 31, 2021 will be used to conduct the Phase 2/3 clinical study and efforts to obtain regulatory and ethical market approval of QR-110 for LCA10.

PRQR ProQR Therapeutics
$18.00

-0.16 (-0.88%)

11/13/18
CANT
11/13/18
INITIATION
Target $40
CANT
Overweight
ProQR Therapeutics initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald initiated ProQR Therapeutics with an Overweight and $40 price target.
11/14/18
CANT
11/14/18
INITIATION
Target $40
CANT
Overweight
Cantor starts ProQR with Overweight despite 500% year-to-date rally
Cantor Fitzgerald analyst Eliana Merle last night initiated coverage of ProQR Therapeutics with an Overweight rating and $40 price target. ProQR is a European RNA-based platform technology company focused on developing therapeutics for inherited blindness, Merle tells investors in a research note. Although shares are up close to 500% year-to-date after positive proof of concept in first ophthalmology drug QR-110, "this could be just the beginning of a major turning point for the company's platform," says the analyst. He thinks QR-110 "could be just the tip of the iceberg" in terms of ProQR's platform potential in inherited forms of blindness. Merle believes its clinical program in Usher's syndrome represents a larger opportunity than QR-110.
11/14/18
11/14/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Avid (AVID) initiated with a Hold at Jefferies. 2. ProQR Therapeutics (PRQR) initiated with an Overweight at Cantor Fitzgerald. 3. GW Pharmaceuticals (GWPH) initiated with an Outperform at Leerink. 4. Equitrans Midstream (ETRN) initiated with an Overweight at US Capital Advisors. 5. Zymogenetics (ZGEN) and Allergan (AGN) were initiated with an Outperform at Leerink. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/15/18
SBSH
11/15/18
INITIATION
Target $32
SBSH
Buy
ProQR Therapeutics initiated with a Buy at Citi
Citi analyst Yigal Nochomovitz started ProQR Therapeutics (PRQR) with a Buy rating and $32 price target. The company's lead program for Leber congenital amaurosis 10, a severe eye disease leading to childhood blindness, has achieved proof-of-concept, Nochomovitz tells investors in a research note. The data reflect a degree of visual benefit "arguably better" than what Spark Therapeutics' (ONCE) Luxturna showed in the related disease LCA2, says the analyst.

TODAY'S FREE FLY STORIES

BTI

British American Tobacco

$36.83

-0.405 (-1.09%)

, MO

Altria Group

$47.71

0.77 (1.64%)

11:47
11/20/19
11/20
11:47
11/20/19
11:47
Periodicals
FDA shelves plan to require sharp cut in nicotine in cigarettes, Bloomberg says »

Bloomberg reported that a…

BTI

British American Tobacco

$36.83

-0.405 (-1.09%)

MO

Altria Group

$47.71

0.77 (1.64%)

PM

Philip Morris

$84.12

0.67 (0.80%)

IMBBY

Imperial Brands

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

GOOGL

Alphabet Class A

$1,306.83

-5.76 (-0.44%)

, GOOG

Alphabet

$1,308.00

-6.71 (-0.51%)

11:45
11/20/19
11/20
11:45
11/20/19
11:45
Periodicals
Some who pre-ordered Google Stadia still can't access service, Kotaku says »

Some customers who…

GOOGL

Alphabet Class A

$1,306.83

-5.76 (-0.44%)

GOOG

Alphabet

$1,308.00

-6.71 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPC

Marathon Petroleum

$61.17

-0.67 (-1.08%)

11:45
11/20/19
11/20
11:45
11/20/19
11:45
Options
Marathon Petroleum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:45
11/20/19
11/20
11:45
11/20/19
11:45
General news
Treasury's $15 B 16-day cash management bill (CMB) stopped at 1.540% »

Treasury's $15 B…

VZ

Verizon

$59.19

-0.31 (-0.52%)

11:39
11/20/19
11/20
11:39
11/20/19
11:39
Hot Stocks
Verizon and Respond unveil third 5G First Responder Lab cohort »

Verizon, in partnership…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 30

    Jan

AMRN

Amarin

$20.18

-2.56 (-11.26%)

, BRY

Berry Petroleum

$7.13

-1.77 (-19.89%)

11:39
11/20/19
11/20
11:39
11/20/19
11:39
On The Fly
Bearish view of Amarin, Berry downgrades among today's top analyst calls »

Check out today's top…

AMRN

Amarin

$20.18

-2.56 (-11.26%)

BRY

Berry Petroleum

$7.13

-1.77 (-19.89%)

TW

Tradeweb Markets

$44.64

1.38 (3.19%)

CBOE

Cboe Global Markets

$121.85

-0.68 (-0.55%)

CGC

Canopy Growth

$17.43

2.11 (13.77%)

I

Intelsat

$7.38

1.3 (21.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 28

    Dec

SYBT

S.Y. Bancorp

$40.66

-0.04 (-0.10%)

11:37
11/20/19
11/20
11:37
11/20/19
11:37
Hot Stocks
S.Y. Bancorp increases quarterly dividend 4% »

Stock Yards Bancorp,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

HUYA

Huya

$21.90

-0.59 (-2.62%)

11:35
11/20/19
11/20
11:35
11/20/19
11:35
Options
HUYA put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

UBER

Uber

$28.35

1.32 (4.88%)

11:25
11/20/19
11/20
11:25
11/20/19
11:25
Options
Uber call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 04

    Dec

SQ

Square

$67.18

0.75 (1.13%)

, PYPL

PayPal

$104.73

-0.21 (-0.20%)

11:25
11/20/19
11/20
11:25
11/20/19
11:25
Conference/Events
Wedbush payments/IT services analyst to hold an advisor luncheon »

Payments/IT Services…

SQ

Square

$67.18

0.75 (1.13%)

PYPL

PayPal

$104.73

-0.21 (-0.20%)

WP

Worldpay

$0.00

(0.00%)

GPN

Global Payments

$181.54

-0.21 (-0.12%)

TSS

TSYS

$0.00

(0.00%)

FDC

First Data

$0.00

(0.00%)

EVOP

EVO Payments

$27.31

-0.19 (-0.69%)

IIIV

i3 Verticals

$23.04

0.19 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 22

    Nov

  • 09

    Dec

  • 10

    Dec

  • 07

    Jan

  • 08

    Jan

  • 26

    Feb

GNPX

Genprex

$0.52

-0.0986 (-15.90%)

11:20
11/20/19
11/20
11:20
11/20/19
11:20
Syndicate
Genprex annoucnes $1.26M registered direct offering »

Genprex announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TDC

Teradata

$27.21

0.315 (1.17%)

11:20
11/20/19
11/20
11:20
11/20/19
11:20
Recommendations
Teradata analyst commentary  »

Teradata interim CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
11/20/19
11/20
11:17
11/20/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLSN

Nielsen

$20.18

-0.02 (-0.10%)

11:16
11/20/19
11/20
11:16
11/20/19
11:16
Initiation
Nielsen initiated  »

Nielsen initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
11/20/19
11/20
11:16
11/20/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$43.50

-0.22 (-0.50%)

11:15
11/20/19
11/20
11:15
11/20/19
11:15
Options
Foot Locker put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

MTZ

MasTec

$66.46

-4.55 (-6.41%)

11:11
11/20/19
11/20
11:11
11/20/19
11:11
Recommendations
MasTec analyst commentary  »

MasTec price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

AMZN

Amazon.com

$1,761.95

9.78 (0.56%)

11:09
11/20/19
11/20
11:09
11/20/19
11:09
Hot Stocks
Amazon.com to create 500 jobs at new fulfillment center in Auburndale, Florida »

Amazon announced plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

STZ

Constellation Brands

$185.90

4.93 (2.72%)

11:05
11/20/19
11/20
11:05
11/20/19
11:05
Options
Constellation Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TDC

Teradata

$26.93

0.04 (0.15%)

11:05
11/20/19
11/20
11:05
11/20/19
11:05
Hot Stocks
Teradata discloses compensation arrangements granted to interim CEO »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFFI

C&F Financial

$52.65

(0.00%)

11:00
11/20/19
11/20
11:00
11/20/19
11:00
Hot Stocks
C&F Financial raises quarterly dividend 2.7% to 38c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPWR

SunPower

$7.96

-0.57 (-6.68%)

10:55
11/20/19
11/20
10:55
11/20/19
10:55
Options
SunPower put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

CRM

Salesforce

$165.46

1.44 (0.88%)

10:55
11/20/19
11/20
10:55
11/20/19
10:55
Conference/Events
Salesforce to host investor day at Dreamforce 2019 »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Dec

  • 16

    Dec

LIVN

LivaNova

$78.56

-0.65 (-0.82%)

10:46
11/20/19
11/20
10:46
11/20/19
10:46
Recommendations
LivaNova analyst commentary  »

LivaNova restructuring…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

MO

Altria Group

$47.34

0.4 (0.85%)

10:45
11/20/19
11/20
10:45
11/20/19
10:45
Options
Altria Group call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.